Lipoate is an essential cofactor for enzymes that are important for central metabolism and other processes. In malaria parasites, scavenged lipoate from the human host is required for survival. The Plasmodium falciparum mitochondrion contains two enzymes (Pf LipL1 and Pf LipL2) that are responsible for activating mitochondrial proteins through the covalent attachment of lipoate (lipoylation). Lipoylation occurs via a novel redox-gated mechanism that remains poorly understood. We show that Pf LipL1 functions as a redox switch that determines which downstream proteins will be activated. Based on the lipoate redox state, Pf LipL1 either functions as a canonical lipoate ligase or as a lipoate activating enzyme which works in conjunction with Pf LipL2. We demonstrate that Pf LipL2 is a lipoyltransferase and is a member of a novel clade of lipoate attachment enzymes. We show that a LipL2 enzyme from Chlamydia trachomatis has similar activity, demonstrating conservation between intracellular pathogens from different phylogenetic kingdoms and supporting the hypothesis that an early ancestor of malaria parasites once contained a chlamydial endosymbiont. Redoxdependent lipoylation may regulate processes such as central metabolism and oxidative defense pathways.
Introduction
Plasmodium falciparum (Pf ) is an apicomplexan parasite and the causative agent of the most severe form of human malaria Mudhune et al., 2011; Okiro et al., 2011) . During their lifecycle, these parasites cycle between sexual and asexual stages in the mosquito vector and human host respectively. Within the human host, malaria parasites first infect the liver followed by a cyclical infection of red blood cells. The latter is the asexual reproductive cycle which corresponds to the symptomatic phase of malaria, with the majority of malaria drugs targeting the blood stage for treatment and cure (Delves et al., 2012) . However, recent reports indicate an alarming increase in resistance to currently available drugs, creating a need to identify new drug targets in the parasite (Fidock et al., 2008; Okiro et al., 2011; Dondorp et al., 2011; Phyo et al., 2012) .
Lipoate metabolism is essential for malaria parasite survival (Allary et al., 2007; Storm, 2012) . Lipoate is an essential cofactor for aerobic metabolism in oxidative decarboxylation reactions of 2-oxoacid complexes (comprised of three subunits named E1, E2 and E3) and for the glycine cleavage system (GCV) . Lipoate is attached by dedicated enzymes to a conserved lysine in the E2 subunits or the H-protein of the GCV . In Pf, lipoate metabolism is partitioned between two organelles, namely the apicoplast (a non-photosynthetic plastid organelle) and the mitochondrion (Foth et al., 2003; Wrenger and M€ uller, 2004; G€ unther et al., 2005; Allary et al., 2007) . Studies in Pf and rodent models of malaria demonstrated that the apicoplast harbors the machinery responsible for the biosynthesis of lipoate, which is dispensable in the blood stage but essential for the parasite's progression from the liver to the blood stage (Foth et al., 2003; Falkard et al., 2013) . By contrast, the mitochondrion relies entirely on lipoate scavenged from the host (Allary et al., 2007) . This pathway has been shown to be essential for parasite survival during both the liver and blood stages (Allary et al., 2007; Storm, 2012; Deschermeier et al., 2012; Falkard et al., 2013) . Furthermore, treatment with lipoate analogs, , causes parasite cell growth inhibition likely due to inhibition of the activity of the mitochondrial lipoylation substrate (Allary et al., 2007; Afanador et al., 2014) .
Three lipoylated substrates have been localized to the mitochondrion: the branched chain dehydrogenase (BCDH) (PF3D7_0303700), the a-ketoglutarate dehydrogenase (KDH) (PF3D7_1320800), and the H-protein (PF3D7_1132900) of the GCV Afanador et al., 2014) . These three mitochondrial proteins are lipoylated through two distinct routes involving the proteins Pf LipL1 (PF3D7_1314600) and Pf LipL2 (PF3D7_0923600). Pf LipL1 is the only lipoate ligase in the mitochondrion and is solely responsible for lipoylation of the H-protein (Afanador et al., 2014) . BCDH and KDH are lipoylated through a second mechanism that requires both Pf LipL1 and Pf LipL2 (Afanador et al., 2014) . These two lipoylation pathways have a strong dependence on the lipoate redox state since lipoylation of the BCDH and KDH requires fully reduced lipoate (dihydrolipoate), while lipoylation of the H-protein does not (Afanador et al., 2014) . This redox-dependent mechanism of controlling lipoate metabolism has not been described in other organisms. Although Pf LipL1 and Pf LipL2 are both required for protein lipoylation in the mitochondrion, the mechanistic role that each protein plays remains poorly understood. Furthermore, the nature of the molecular switch that determines which lipoylation route proceeds (and therefore which parasite proteins will be activated through lipoylation) has remained elusive in previous studies.
Herein we use recombinant lipoate attachment enzymes and the lipoylation domains (LD) of substrate proteins to understand how proteins are lipoylated in malaria parasites. We show that lipoylation of BCDH LD and KDH LD in the presence of chemically synthesized lipoyl-AMP and Pf LipL2 is independent of Pf LipL1. This is consistent with the idea that the lipoylation of the BCDH LD and KDH LD proceeds through a sequential mechanism in which Pf LipL1 activates lipoate with ATP to form lipoyl-AMP, and Pf LipL2 acts as a lipoyltransferase to lipoylate the BCDH LD and KDH LD utilizing the lipoyl-AMP as a substrate (Fig. 1 ). This work also shows that Pf LipL2 is not redox sensitive, but rather it is Pf LipL1 that recognizes the redox state of lipoate and acts as a molecular switch defining which substrate proteins will be lipoylated downstream. Lastly, Pf LipL2 represents a new family of lipoate attachment enzymes that is conserved across kingdoms, including other Plasmodium species and the bacterial pathogen Chlamydia trachomatis.
Results
Pf LipL2 is an enzyme with lipoyl-AMP:N E -lysine lipoyltransferase activity
Lipoylation of Pf mitochondrial substrate proteins proceeds through two distinct pathways. PfLipL1 is sufficient to lipoylate the H-protein, whereas both PfLipL1 and PfLipL2 are required to lipoylate the BCDH LD and KDH LD (Afanador et al., 2014 (Fig. 2B , lanes 2 & 4) suggesting a possible catalytic role by Pf LipL2. Taken together, these results are consistent with the idea that the role of Pf LipL1 in the combined reaction is to produce lipoyl-AMP and that Pf LipL2 plays a catalytic role in the lipoylation of BCDH LD and KDH LD .
To determine whether PfLipL2 activity requires an interaction with PfLipL1, we tested PfLipL2 in the presence of lipoyl-AMP alone. As shown in Fig. 2C were lipoylated under all conditions tested implying that Pf LipL2 is not redox sensitive (Fig. 3A , lanes 5-12). We next wanted to determine the redox state of lipoate (or lipoyl-AMP) under the reaction conditions used in our lipoylation assays. To accomplish this, we developed a method to measure the reduction of lipoate using the mitochondrial Pf dihydrolipoamide dehydrogenase (mLipDH or E3 subunit, PF3D7_1232200). PfmLipDH is a flavin dependent enzyme that can catalyze the oxidation of dihydrolipoamide with the concomitant reduction of NAD 1 to NADH (McMillan et al., 2004) .
Recombinant PfmLipDH was expressed and purified, and the production of NADH was monitored by absorbance at 340 nm in the presence of lipoate and various reducing agents. At pH 7.5, TCEP rapidly reduces lipoate while DTT displays little reduction activity (Supporting Information Fig. S1 ). At pH 9.3, corresponding to the pKa of DTT (Lukesh et al., 2012) , the amount of reduced DTT increases slightly, presumably due to the increased prevalence of the active thiolate form of DTT at higher pH. These results are consistent with the observation that TCEP, but not DTT, is an effective reducing agent for lipoate (Burns et al., 1991) .
To test the hypothesis that Pf LipL1 acts as a sensor for the redox state of lipoate, we incubated lipoate with a strong reducing agent (TCEP or THP) for a 5-min period prior to a ligation reaction to ensure full reduction. We then proceeded to add Pf LipL1 to test its ability to lipoylate the H-protein with dihydrolipoate. As seen in Fig. 3B , Pf LipL1 is unable to lipoylate the H-protein with dihydrolipoate, but can modify it with lipoate (treated with DTT or no reducing agent). Taken together these observations implicate Pf LipL1 as a redox switch determining the fate of scavenged lipoate in the parasite mitochondrion.
TCEP reduces the affinity of Pf LipL1 for lipoate and lipoyl-AMP To further characterize the redox sensitivity of PfLipL1, we used a thermal shift assay (Afanador et al., 2013) to extract binding constants from the stabilization of PfLipL1 upon binding of lipoate, the intermediate lipoyl-AMP, and dichloro analogs of these compounds that mimic the reduced state of lipoate [6, and 6,8-dichlorooctanoyl-AMP (6,8-diClO-AMP)]. Additionally, we characterized the PfLipL1-ligand interaction by isothermal titration calorimetry when the conditions were appropriate, and the results are summarized in Table 1 . In the absence of reducing agent, both lipoate and lipoyl-AMP bind tightly to PfLipL1 with relative binding affinities (K d ) of 0.130 lM and 0.020 lM respectively. By contrast, PfLipL1 has a K d of 94 lM and 5.8 lM for dihydrolipoate and dihydrolipoyl-AMP respectively. This accounts for a 723-fold weaker affinity between the oxidized and reduced forms of lipoate and a 290-fold drop in affinity between the oxidized and reduced forms of lipoyl-AMP. Furthermore, the reduced state mimics 6,8-diClO and 6,8-diClO-AMP bind with K d values of 13 lM and 0.09 lM respectively. These two analogs are virtually unaffected by the presence of reducing agent which results in a K d of 18 lM and 0.25 lM for 6,8-diClO and 6,8-diClO-AMP respectively. This is equivalent to only a 1.4-fold and 2.8-fold drop in affinity in the presence of reducing agent. PfLipL1 binds tightly to lipoyl-AMP (oxidized form) and is able to modify the H-protein in a canonical two step ligation reaction. However, under reducing conditions, the affinity of PfLipL1 for dihydrolipoyl-AMP (reduced form) shifts 290 fold from 0.02 mM to 5.8 mM. The weaker binding affinity of dihydrolipoyl-AMP may enhance direct transfer of the conjugate to PfLipL2, or facilitate release of the conjugate, making it available for subsequent binding to PfLipL2. Table 1 . Binding affinities of Lipoate, 6,8-diClO, and adenylated substrates for Pf LipL1 under reducing and non-reducing conditions determined by thermal shift assay (TSA) and isothermal titration calorimetry (ITC).
Substrate
Concentration in TSA (lM) An active site lysine is essential for Pf LipL2 activity
Previous studies functionally characterized PfLipL1 including its key catalytic residue (K160) (Afanador et al., 2014) . In most characterized lipoylation systems, a conserved lysine residue in the active site facilitates transfer of the lipoyl moiety from lipoyl-AMP (Fujiwara et al., 2005 (Fujiwara et al., , 2007 (Fujiwara et al., , 2010 . However, sequence alignment failed to identify any essential catalytic residue in PfLipL2. In contrast to PfLipL1, PfLipL2 shares low sequence identity to Escherichia coli lipoate ligase (EcLplA) and Bos taurus lipoyl-AMP:N E -lysine lipoyltransferase (BtLipT) ( Table 2 ) and does not have an apparent conserved lysine residue when aligned to these or other characterized enzymes. In order to identify an essential residue in Pf LipL2, we generated a homology model of Pf LipL2 based on the BtLipT structure (PDB: 2E5A) using the program i-Tasser ( Fig. 4A ) (Zhang, 2008) . Despite poor alignment in a pairwise sequence alignment of BtLipT and Pf LipL2, the resulting homology model of Pf LipL2 contains a lysine residue that is positioned in space near the active site lysine (K135) of BtLipT (Fig. 4A, inset) . This lysine residue in Pf LipL2 (K219) is found downstream of conserved regions in lipoate attachment enzymes (vide infra). We proceeded to express and purify an alanine mutant at position 219 (Pf LipL2 K219A ) and tested the recombinant protein. In a coupled reaction with Pf LipL1, Pf LipL2 K219A prevents the lipoylation of BCDH LD and KDH LD (Fig. 4B) . As predicted, Pf LipL2 K219A is unable to use lipoyl-AMP as a substrate (Fig. 4C) , implying that K219 is involved in the lipoyltransferase reaction. Thus, Pf LipL2 acts as an lipoyl-AMP:N E -lysine lipoyltransferase with an activity analogous to that of BtLipT (Fujiwara et al., 1994 (Fujiwara et al., , 2007 . These results are consistent with the model for lipoylation in P. falciparum mitochondrion summarized in Fig. 1 . A. i-Tasser generated model of LipL2 (cyan) based on BtLipT (PDB: 2E5A) overlaid with the crystal structure of BtLipT (purple) (Zhang, 2008) . Catalytic lysine residues and lipoyl-AMP are shown as stick representation and labeled accordingly. B. Mutational analysis of LipL2 shows that Lys219 but not Cys93 (Afanador et al., 2014) or Cys276 (Afanador et al., 2014) is essential for LipL2 lipoyltransferase activity. C. LipL2 K219A is unable to use lipoyl-AMP to lipoylate the BCDH LD and KDH LD .
LipL2-like activity is present in human pathogens across kingdoms
We next probed the conservation of LipL2-like enzymes in other organisms. Searching for conserved sequence motifs we found a unique pair of motifs that define LipL2-like enzymes. Pattern 1, known as the 'lipoate-
, is conserved in all lipoate attachment enzymes (Fujiwara et al., 2010) . A second region called the 'adenylatebinding loop' is typically characteristic of lipoate attachment enzymes (including Pf LipL1, BtLipT and HsLipT), but is not present in LipL2-like enzymes. However, we identified a second conserved pattern (
) in LipL2-like enzymes located downstream of the 'lipoate-binding loop' (Supporting Information Fig.  S2 ). Using these conserved patterns we identified a family of LipL2-like enzymes across a broad spectrum of organisms including an enzyme in Plasmodium berghei and Chlamydia trachomatis (Supporting Information  Table S1 ).
We cloned, purified, and tested the activity of the putative LipL2-like enzymes from P. berghei (PbLipL2) and C. trachomatis (CtLipL2) for lipoyl-AMP:N E -lysine lipoyltransferase activity. Like Pf LipL2, PbLipL2 is unable to catalyze a lipoate ligation reaction, independent of reducing conditions (Fig. 5A, lanes 1-9) . However, PbLipL2 is able to use lipoyl-AMP as a substrate to lipoylate BCDH LD and KDH LD , but not H-protein (Fig. 5A, . This behavior is the same as we observed for Pf LipL2, including the substrate specificity, suggesting that both parasite species share similar lipoylation mechanisms.
Next we tested the lipoyltransferase activity of CtLipL2 with its cognate substrates. As a first step, we validated that all four substrates (CtH-protein, CtBCDH LD , CtKDH LD and CtPDH LD ) can be lipoylated by the lipoylation machinery of wild type E. coli (Fig. 5B) .
Next, we expressed these Ct proteins in the lipoylation deficient cell line JEG3 to produce the apo-form of these lipoylation domains (Afanador et al., 2014) ; and CtLipL2 was tested with each Ct substrate in the presence of lipoyl-AMP. Like the Plasmodium proteins, CtLipL2 was able to lipoylate CtBCDH LD and CtKDH LD confirming that CtLipL2 has lipoyltransferase activity. Furthermore, CtLipL2 was unable to modify the CtH-protein under reducing or oxidizing conditions demonstrating the same substrate specificity as observed for the parasite congeners (Fig. 5C) . Finally, CtLipL2 lipoate ligase activity was probed in the presence of lipoate and ATP under different reducing conditions. Consistent with what was reported in the literature (Ramaswamy and Maurelli, 2010) , CtLipL2 is not a lipoate ligase and is unable to lipoylate any Ct substrate under any of the conditions tested (Fig. 5D) . Taken together these data show that CtLipL2 is a lipoyltransferase with an activity similar to what we observed for Pf LipL2 and PbLipL2.
Discussion
To understand the role of Pf LipL1 in the coupled Pf LipL1/Pf LipL2 lipoylation reaction we generated an inactive mutant, Pf LipL1 K160A . Pf LipL1 K160A is unable to lipoylate any substrate enzyme in an ATP-dependent reaction presumably due to the inability to form the lipoyl-AMP conjugate (Afanador et al., 2014) . A similar result was observed in a K133A LplA mutant in E. coli (Fujiwara et al., 2010) . Even in the presence of chemically synthesized lipoyl-AMP, Pf LipL1 K160A is unable to catalyze the transfer reaction with the H-protein (Fig.  2B, lane 1) , highlighting the importance of this Lys residue in both ligation and transfer reactions. As expected, Pf LipL1 K160A was unable to modify either the BCDH or KDH in a transfer reaction but did not prevent their lipoylation when Pf LipL2 was present in the reaction (Fig.  2B) . Thus, Pf LipL2 is sufficient to modify the BCDH and KDH when lipoyl-AMP is supplied (Fig. 2C ). These observations are consistent with the characterization of Pf LipL1 as the only canonical lipoate ligase in the parasite mitochondrion with a mechanism of action analogous to what was observed for the E. coli lipoate ligase (Fujiwara et al., 2010) . However, unlike in E. coli, where the lipoate ligase is sufficient to modify all canonical substrates in a ligation reaction, Pf LipL1 can only modify the H-protein, and not the BCDH or KDH.
The mechanism for the lipoylation of the BCDH and KDH is more similar to the bovine system in which it has been reported that a lipoate activating enzyme activates lipoate with GTP, and a lipoyl-GMP:N E -lysine lipoyltransferase (BtLipT) then transfers the lipoyl moiety from the formed conjugate (lipoyl-GMP) to the substrates (Fujiwara et al., 1994 (Fujiwara et al., , 2001 (Fujiwara et al., , 2007 -lysine lipoyltransferase which lipoylates the BCDH and KDH, but with several differences compared to any other described system. First, LipL1 has dual activity as the lipoate ligase required for H-protein lipoylation and as a lipoateactivating enzyme catalyzing the formation of the lipoyl-AMP conjugate. In mammalian systems, the latter role has been reported to be catalyzed by a medium chain acyl-CoA synthetase (Fujiwara et al., 2001) . Second, mammalian systems use GTP to activate lipoate (Fujiwara et al., 2001) , whereas Pf uses ATP exclusively (Afanador et al., 2014) . Finally and perhaps most strikingly, is the difference in the dependence on the redox state of lipoate. In the mammalian system, lipoate activation and subsequent transfer by BtLipT proceeds in the presence of DTT which is insufficient to reduce lipoate (Fujiwara et al., 1994) . By contrast, Pf lipoylation of BCDH and KDH requires the reduction of lipoate for the reaction to proceed and does not occur in the presence of DTT (Afanador et al., 2014) .
Redox dependent lipoylation in P. falciparum mitochondria may affect central metabolism through the coordinated activation of BCDH and KDH. Work by other groups has shown that BCDH functions as a pyruvate dehydrogenase generating acetyl-CoA in the mitochondrion, and that KDH has the expected enzymatic activity of an alpha-ketoglutarate dehydrogenase (Cobbold et al., 2013; Oppenheim et al., 2014; Ke et al., 2015) . These proteins are both components of the tricarboxylic acid (TCA) cycle, raising the possibility that protein lipoylation regulates the activity of this pathway. TCA cycle activity is thought to be critical for parasite survival during different life cycle stages, such as the mosquito stage (Ke et al., 2015; Srivastava et al., 2016) , suggesting a critical role for lipoylation during these stages of parasite development. Additionally, lipoylation of BCDH may be important for generating acetyl-CoA for acetylation reactions in other subcellular compartments of the parasite, such as the cytosol and nucleus. A requirement for acetyl-CoA in these compartments may explain the toxicity of the lipoate analog 6,8-diClO which appears to be covalently attached to BCDH and KDH in treated parasites (Afanador et al., 2014) . Since KDH and other TCA cycle enzymes are dispensable in blood stage P. falciparum parasites (Ke et al., 2015) , inhibition of BCDH is presumably responsible for blood stage parasite growth inhibition by 6,8-diClO.
The role of the H-protein is more difficult to discern because it is unlikely to function as part of a glycine cleavage system due to the lack of an identifiable Pprotein in the parasite genome (Salcedo et al., 2005; Nickel et al., 2006; ). An intriguing possibility is that the H-protein could function as part of an oxidative stress pathway analogous to those observed in T. vaginalis and M. tuberculosis (Bryk et al., 2002; N yvltov a et al., 2016) . A similar mechanism involving the antioxidant properties of lipoate may be important for malaria parasites (Bunik, 2003; M€ uller, 2004) . In this context, the redox-dependent lipoylation of the H-protein that we observe in vitro may make sense since H-protein lipoylation would tend to increase under conditions of elevated oxidative stress. This scenario is not hard to imagine since the glutathione redox potential in the mitochondria of blood stage P. falciparum parasites is 2328 mV (Mohring et al., 2017) , a value similar to that of lipoate.
Orthologs of Pf LipL1 and Pf LipL2 are found in several other organisms, suggesting that lipoylation mechanisms may be conserved. We tested the activity of a rodent malaria parasite (Plasmodium berghei) LipL2 with the Pf substrates and found that this enzyme has lipoyltransferase activity and lipoylates the same proteins (BCDH and KDH, but not the H-protein) as Pf LipL2 (Fig. 5A) . Additionally, we studied a LipL2 ortholog from the intracellular pathogen Chlamydia trachomatis. Similar to Plasmodium species, C. trachomatis possesses a LipL1-like enzyme which has been shown to be an active ligase, but no enzymatic activity was described for CtLipL2 (Ramaswamy and Maurelli, 2010) . We now show that CtLipL2 behaves as a lipoyltransferase with its cognate substrates and that it does not possess any ligation activity in vitro (Fig. 5C,D) . Pf LipL2 and other LipL2-like enzymes are members of the cofactor transferase family (PF03099) and appear to form a distinct clade of lipoate attachment enzymes found in prokaryotic and eukaryotic species (Fig. 6) (Finn et al., 2010; Christensen et al., 2011) . LipL2 orthologs found in these species may be evidence of horizontal gene transfer from an ancient chlamydial endosymbiotic event with a primary photosynthetic eukaryote (Huang and Gogarten, 2007) .
The Pf LipL1/Pf LipL2 reaction proceeds in a sequential order, however, it remains unclear if a direct interaction between the two enzymes needs to take place or if dihydrolipoyl-AMP is released from Pf LipL1 due to the low binding affinity. We decided to address this question by determining whether there is a specific interaction between LipL1 and LipL2 enzymes consistent with a direct transfer mechanism (Supporting Information Fig.  S4 ). We found that Pf LipL1 and PbLipL2 can function together to lipoylate both PfKDH LD and PfBCDH LD . Similarly, we found that Pf LipL1 and CtLipL2 can lipoylate both CtKDH LD and CtBCDH LD . The ability of Pf LipL1 to function with parasite or bacterial LipL2 enzymes suggests that there is not a specific protein-protein interaction between LipL1 and LipL2 enzymes. These results are consistent with the release of dihydrolipoyl-AMP from LipL1 followed by subsequent binding to LipL2. It is also possible that despite the low sequence identity between Pf LipL2 and CtLipL2 (22%) there is some conserved sequence and structure motif responsible for cross-species recognition.
In the current study, we have expanded the understanding of mitochondrial lipoylation in Pf. The parasite mitochondrion contains two lipoate attachment enzymes (Pf LipL1 and Pf LipL2) and three lipoate requiring substrate enzymes (H-protein, BCDH and KDH) that are lipoylated through two mutually exclusive routes gated by (Morris et al., 1995) are colored red, sequences similar to Listeria monocytogenes LipL amidotransferase (Christensen et al., 2011) are colored purple, sequences similar to Bacillus subtilis LipM octanoyltransferase (Christensen and Cronan, 2010) are colored blue, sequences similar to Bos tarus LipT mammalian lipoyltransferase (Fujiwara et al., 1994) , 2016) , it is an intriguing possibility that the redox sensitivity described herein may be part of a larger regulatory mechanism that is linked to the redox state of parasite mitochondria.
Experimental procedures

Materials
The reducing agents used in this study were obtained from Fluka (TCEP; tris(2-carboxyethyl)phosphine), Calbiochem (THP; tris(hydroxypropyl)phosphine), and Sigma-Aldrich (DTT; dithiothreitol). Antibodies were purchased from Calbiochem (rabbit a-LA polyclonal antibodies) and GE Healthcare (donkey a-Rabbit IgG HRP conjugate). Specific rabbit polyclonal antibodies (a-LA 891 ) were generated and purified as described below. The following chemicals were purchased from Sigma-Aldrich: ATP, NAD 1 and R-LA. The compound 6,8-diClO was synthesized as described in reference (Afanador et al., 2014) . The adenylated conjugates 6,8-diClO-AMP and lipoyl-AMP were synthesized as described below.
Synthesis of lipoyl-AMP and 6,8-dichlorooctanoyl-AMP
Procedures for synthesis of Lipoic Acid-Adenosine Monophosphate Mixed Anhydrides were based on Reed et al. with modifications (Reed et al., 1958) . All reagents were obtained from commercial suppliers and used without further purification unless stated. Acetonitrile was distilled after drying on CaH 2 then stored over 3Å molecular sieves. Yields of all reactions refer to the purified products. 1 H spectra were acquired on a Bruker Avance III 500 spectrometer operating at 500 MHz. Chemical shift values are reported as d (ppm) relative to DMSO at d 2.50 ppm. The purity of synthesized compounds was analyzed by HPLC (Beckman Gold Nouveau System Gold) on a C 18 column (Grace Alltima 3 mm C 18 analytical RocketV R column, 53 mm 3 7 mm) using triethylammonium acetate buffer (50 mM, pH 6) and methanol as eluent, flow rate 3 mL/min, and detection at 260 nm. (R)-5-(1,2-dithiolan-3-yl)pentanoic (((2R,3S,4R,5R) -5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl) methyl phosphoric) anhydride monosodium salt (Lipoyl-AMP, LA-AMP). R-Lipoic acid (0.500 g, 2.42 mmol) was dissolved in acetonitrile (2.5 mL) and added to a solution of dicyclohexylcarbodiimide (0.250 g, 1.21 mmol) in acetonitrile (0.9 mL) and the mixture was stirred at ambient temperature for 30 min. The resulting suspension was then transferred to a conical tube and centrifuged (5 min, 4000 rpm) to pellet the solid. The supernatant containing the R-lipoic acid anhydride was added to a solution of adenosine monophosphate monohydrate (0.442 g, 1.21 mmol) in pyridine (3.68 mL) and water (7.81 mL) at 08C. After stirring the mixture at 08C for 50 min, water (10 mL) was added and the solution was transferred to a separatory funnel where it was washed with ice-cold diethyl ether (2 3 10 mL) and then ice-cold chloroform (2 3 10 mL). The aqueous layer was collected and acetone was added to precipitate residual adenosine monophosphate, which was removed by centrifugation (5 min, 4000 rpm). The supernatant was then condensed under reduced pressure and redissolved in a minimum volume of water before being loaded onto a C 18 solid phase extraction column, washed with water (10 mL), and eluted with acetonitrile. Condensation in vacuo yielded the desired product in 96% purity (0.006 g, 0.01 mmol, 1% yield). 6,8-Dichlorooctanoic (((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl phosphoric) anhydride monosodium salt (6,8-dichlorooctanoyl-AMP, diCl-AMP). 6,8-Dichlorooctanoic acid (0.300 g, 1.41 mmol) was dissolved in dichloromethane (2.9 mL) and dicyclohexylcarbodiimide (0.145 g, 0.704 mmol) was added. After stirring for 30 min, the solid was removed by filtration and washed with dichloromethane. The filtrate was collected and condensed under reduced pressure. The resulting oil was dissolved in pyridine (1.7 mL), cooled to 08C and then added to a solution of adenosine monophosphate monohydrate (0.257 g, 0.704 mmol) in pyridine (1.7 mL) and water (2.2 mL) at 08C. The solution was stirred at 08C for 60 min. Water (10 mL) was added, and the solution was transferred to a separatory funnel where it was washed with ice-cold diethyl ether (2 3 10 mL) and then ice-cold chloroform (2 3 10 mL). The aqueous layer was collected and condensed under reduced pressure. The resulting residue was dissolved in a minimum volume of saturated aqueous NaHCO 3 and loaded on a C 18 solid phase extraction column and washed with water (10 mL) and then eluted with acetonitrile. Condensation in vacuo yielded the desired product in 97% purity (0.005 g, 0.01 mmol, 1% yield). 
Protein expression and purification
Cloning, expression and purification of the lipoylation domains of PfBCDH (PF3D7_0303700) and PfKDH (PF3D7_1320800), the H-protein (PF3D7_1132900), as well as LipL1 (PF3D7_1314600) and LipL2 (PF3D7_0923600) were previously described (Afanador et al., 2014) . The genes encoding the lipoylation enzymes were cloned into the expression plasmid pMALcHT, which encodes a maltose binding protein (MBP) followed by a linker region composed of a tobacco etch virus (TEV) protease cut site and a six histidine affinity tag (Muench et al., 2003) . The plasmid pMALcHT-Pf LipL1 (Afanador et al., 2014) was mutated by site directed mutagenesis to generate pMALcHTPf LipL1 K160A using the primers listed in Supporting Information Table S2 . This plasmid was transformed into BL21-Star (DE3) cells (Invitrogen) and co-transformed with the pRIL plasmid isolated from BL21-CodonPlus-RIL cells (Agilent) and the plasmid pKM586 encoding the TEV protease, as described (Muench et al., 2003) . The resulting transformed cells produced Pf LipL1 K160A fused to an amino-terminal six histidine-tag. For protein expression, cells were grown to mid-log phase and protein expression was induced by the addition of 0.4 mM IPTG. Cells were harvested after growth for 10 h at 208C. Recombinant Pf LipL1 K160A was purified by metal chelate chromatography followed by cation exchange chromatography.
Plasmid pMALcHT-Pf LipL2, encoding a codon harmonized variant (Afanador et al., 2014) , was mutated by sitedirected mutagenesis using primers listed in Supporting Information Table S2 to generate pMALcHT-LipL2 K219A . Plasmid pMALcHT-Pf LipL2 K219A was transformed into BL21-Star (DE3) and co-transformed with the pRIL plasmid. These cells produce LipL2 fused to an amino-terminal MBP. LipL2 K219A was purified using Amylose resin (New England Biolabs #E8021).
PbLipL2 (PBANKA_0824500) was cloned from Plasmodium berghei ANKA genomic DNA (a generous gift from the Sinnis Lab) into pMALcHT using primers PbLipL2.fwd and PbLipL2.rev listed in Supporting Information Table S2 . Similar to LipL2 constructs, pMALcHT-PbLipL2 was transformed into BL21-Star (DE3) and co-transformed with the pRIL plasmid. These cells produced PbLipL2 fused to an amino-terminal MBP, which was purified using Amylose resin.
CtLipL2 (AAC68100) was cloned from C. trachomatis Serovar D strain UW-3/Cx gDNA (purchased from ATCC) into plasmid pMALcHT using primers CtLipL2.fwd and CtLipL2.rev listed in Supporting Information Table S2 . pMALcHT-CtLipL2 was transformed in BL21-Star (DE3), cotransformed with the pRIL plasmid, and expressed for 10 hours at 208C. The MBP-tagged CtLipL2 was purified by affinity chromatography (MBPTrap, GE Healthcare Life Sciences).
CtHprotein (AAC67875), CtBCDH (AAC67997) and CtPDH (AAC67840) were cloned from C. trachomatis Serovar D strain UW-3/Cx genomic DNA (purchased from ATCC) into plasmid pGEXTK using primers CtHprotein.fwd and CtHprotein.rev, CtBCDH.fwd and CtBCDH.rev, and CtPDH.fwd and CtPDH.rev listed in Supporting Information Table S2 . Expression plasmid pGEXTK is a modified version of pGEXT (Delli-Bovi et al., 2010) containing a kanamycin selection cassette. Codon-optimized CtKDH (synthesized by GeneArt) was digested with BamHI and SalI and inserted into pGEXTK to yield pGEXTK-CtKDH. All plasmids were transformed into BL21-Star (DE3) along with the pRIL plasmid. CtHprotein and CtBCDH were expressed for 3 h at 378C while CtPDH and CtKDH were expressed for 10 h at 208C. The resulting GST-fusion proteins were purified by affinity chromatography (GSTrap, GE Healthcare Life Sciences).
Lipoylation assays
Purified recombinant enzymes (1 mM) were incubated in reaction buffer (100 mM Na 1 /K 1 phosphate buffer, 150 mM NaCl at pH 7.5) containing (unless otherwise stated) 2 mM ATP, 2 mM MgCl 2 , 5 mM TCEP, 200 mM Rlipoic acid and 10 mM apo-protein substrate. The reactions were incubated at 378C for 1 h and quenched with the addition of gel loading buffer. Proteins were then resolved by SDS-PAGE and transferred to nitrocellulose membrane for Western blotting. Membranes were blocked with 5% milk in PBS for 30 minutes, and probed with 1:5000 rabbit polyclonal a-LA 891 (see below) for 1 hour in 1% milk/PBS at room temperature. The membrane was then washed with PBS three times and probed with 1:5000 donkey aRabbit IgG horseradish peroxidase (HRP) secondary antibody (GE Healthcare) in 1% milk/PBS overnight at 48C. Proteins were visualized using enhanced chemiluminescence (ECL) western substrate (Pierce) by exposure to film.
All lipoylation assays were conducted similarly using the same protein concentrations and base buffer. Where indicated, ATP was omitted from the reaction and 5 mM of DTT, 5 mM THP or water was used instead of TCEP. When noted, R-lipoic acid was substituted with 1 or 10 mM R-lipoyl-AMP as the sole lipoate source, with no ATP added.
Cell-based lipoylation assay E. coli BL21 cells were transformed with the pGEXTKCtHprotein, pGEXTK-CtBCDH, pGEXTK-CtKDH and pGEXTK-CtPDH plasmids and grown in LB media in the presence of kanamycin. For the cell-based assay, 20 mL cultures were grown to mid-log phase at 378C and protein expression was induced with 0.4 mM IPTG for 10 hours at 208C. Cells were harvested by centrifugation and resuspended with 0.5 mL of buffer containing 20 mM HEPES, 100 mM NaCl at pH 7.5 and lysed by sonication. Cell lysates were clarified by centrifugation at 16000 g. The supernatants were collected, and the proteins were resolved by SDS-PAGE. Lipoylated proteins were visualized by Western blot as described for the lipoylation assays.
Thermal shift assay
Thermal shift assays were performed using a previously described method with minor modifications as follows (Afanador et al., 2013) . Real-time PCR tube strips (Eppendorf) were used to hold 31 mL mixtures containing final concentrations of 1 mM LipL1, 10 mM of ligand (R-LA, R-Lipoyl-AMP or 6,8-diClO) diluted in DMSO. The reactions were set up with a 29 mL mixture containing LipL1, buffer (100 mM Na/K Phosphate pH 7.5, 150 mM NaCl and 2 mM MgCl 2 ) and Sypro Orange (Sigma, Product Number S-5692 at a final concentration of 5X) to which 1 mL of DSMO (or ligand) and 1 mL of water (or DTT or TCEP diluted in water at a final concentration of 5 mM) were added. The reaction mixture was incubated in a RT-PCR machine (Applied Biosystems, Step One Plus Real-Time PCR System) for 2 min at 208C followed by 0.28C increases in the temperature every 10 s until a final temperature of 808C was reached. During the thermal scan, fluorescence was monitored using a predefined TAMRA filter in which an increase in Sypro Orange fluorescence was observed upon thermal denaturation of LipL1. The derivative of the fluorescence curve was used to determine the melting temperature (T m ). The initial T m in the absence of ligand, but in the presence of DMSO, served as the baseline temperature (T o ) for determining temperature shifts (DT m ). All measurements were made with three technical replicates on three separate occasions.
All binding affinities were calculated as described previously in the literature (Lo et al., 2004; Afanador et al., 2013) , employing the Eq. (1): 
Here T o represents the melting temperature of Pf LipL1 in the absence of ligand, T m represents the melting temperature of Pf LipL1 in the presence of ligand, R is the universal gas constant, DH represents the enthalpy of protein unfolding, DC p represents the change in the heat capacity upon protein unfolding, and [L Tm ] represents the concentration of the free ligand at the melting temperature. Both DH and DC p were determined by Differential Scanning Calorimetry (DSC). A sample of 0.5 mg/mL Pf LipL1 was scanned from 10 to 658C at 18C/min using a VP-DSC microcalorimeter from MicroCal/Malvern Instruments LLC (Northampton, MA). The change in heat capacity, DC p was 5 kcal/mol•K as estimated from the difference between the baselines for the denatured and native states. The unfolding enthalpy (DH) obtained by integration of the peak, was 124.5 kcal/mol. The dissociation constant was calculated at 378C using the Eq. (2):
Here, DH L(T) is the van't Hoff enthalpy of binding at temperature T and estimated to be 215 kcal/mol.
Production and validation of rabbit a-LA 891 antibodies R-lipoic acid was conjugated to keyhole limpet hemocyanin using the Imject EDC mcKLH Spin Kit (Pierce). Antibodies to the conjugate were generated in rabbits using the standard protocol of the custom antibody service Cocalico Biologicals (Reamstown, PA). Specific antibodies were purified from serum using a holo-H-protein affinity column. To make the affinity column, a 1 mL NHS-activated HP column (GE Healthcare) was activated with 1 mM HCl according to the manufacturer's instructions. Immediately after activation, 5 mg of E. coli H-protein in 4 mL of reaction buffer (100 mM NaHCO 3 , 500 mM NaCl pH 8.3) was pumped through the column at a constant rate of 0.1 mL/min. H-protein was circulated through the column for 1 h at room temperature at which point the release of N-hydroxysuccinimide reaction product was quantified by absorbance at 260 nM (E 5 8600 M 21 cm 21 ). The column was subsequently washed and blocked according to the manufacturer's directions. Rabbit antiserum (10 mL) was then circulated over the affinity column at room temperature for 4 h at 0.25 mL/min. Nonspecifically bound proteins were washed from the column with 10 mL of PBS. The bound antibodies were then eluted from the column in 4 mL of 50 mM glycine pH 1.9. A total of 1.44 mg of specific IgG was concentrated to 1 mg/mL and stored at 2808C in storage buffer (PBS, 50% glycerol, 0.02% NaN 3 ). The specific polyclonal antibodies were designated a-LA 891 . To test this new reagent, we generated lipoylated PfH-protein using LipL1, R-LA and ATP in a lipoate ligase reaction, as described above. The resulting reaction mixture was then used to compare a-LA 891 to commercially available a-LA (Calbiochem) by Western blot (Supporting Information Fig. S3 ).
Sequence identity and alignments
The EuPathDB (Aurrecoechea et al., 2010) , including PlasmoDB, ToxoDB and PiroplasmaDB, and the Wellcome Trust Sanger Institute for Eimeria tenella were used for BLAST homology search of LipL2-like enzymes (Ling et al., 2007) . Amino acid sequence identity was calculated by using the MUSCLE algorithm (Edgar, 2004a (Edgar, , 2004b , and sequence alignments were performed with the programs CLUSTALW2 and ESPRIPT2 (Gouet et al., 1999; Thompson et al., 2002) . The superfamily phylogenetic tree was obtained from Pfam entry PF03099 and displayed using Dendroscope by distance methods using boostrap sampling with 100 replicates (Huson et al., 2007) .
